AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Is the Bar Higher Than It Is With Other Studies?
We can look at all this now by stratifying the patients for anti-nephrin positivity and negativity but again we need clean cohorts, cannot work with cohorts that have been treated already. So that's a challenge here and we have to remain really clean otherwise as soon as we use samples that have really nearly been connected at various time points and try to compare them to each other that's not going to work. We were shocked at the responses we got from the reviewers absolutely and a lot of those were some things we could not argue with which was just like this can't be.